Skip to main content
Log in

ICERs favour long-term insulin glargine for diabetes

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Grima DT, Thompson MF, Sauriol L.Modelling cost effectiveness of insulin glargine for the treatment of type 1 and type 2 diabetes in Canada. PharmacoEconomics 25: 253-266, No. 3, 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

ICERs favour long-term insulin glargine for diabetes. Pharmacoecon. Outcomes News 524, 7 (2007). https://doi.org/10.2165/00151234-200705240-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705240-00010

Keywords

Navigation